Skip to main content
. 2024 Jan 16;47(4):629–637. doi: 10.2337/dc23-1401

Table 3.

Association of depressive symptoms and diabetes distress with next-visit medication adherence

Unadjusted Adjusted
Estimates (95% CI) P* Estimates (95% CI) P*
Separate models
 Depressive symptoms
  PHQ-8 total score −0.12 (−0.19, −0.05) 0.0004 −0.10 (−0.16, −0.03) 0.0028
  PHQ-8 somatic symptom score −0.79 (−1.27, −0.32) 0.0011 −0.71 (−1.19, −0.24) 0.0031
  PHQ-8 cognitive-affective score −0.79 (−1.28, −0.31) 0.0013 −0.56 (−1.04, −0.09) 0.0210
 Diabetes distress
  DDS average score −0.98 (−1.33, −0.62) <0.0001 −0.76 (−1.12, −0.41) <0.0001
  DDS emotional burden −0.88 (−1.19, −0.58) <0.0001 −0.70 (−1.01, −0.40) <0.0001
  DDS regimen-related distress −0.81 (−1.08, −0.54) <0.0001 −0.65 (−0.92, −0.39) <0.0001
  DDS physician-related distress −0.19 (−0.52, 0.13) 0.2436 −0.12 (−0.45, 0.20) 0.4645
  DDS interpersonal distress −0.55 (−0.84, −0.26) 0.0002 −0.41 (−0.70, −0.12) 0.0057
Joint models
 Depressive symptoms and diabetes distress
  PHQ-8 total score −0.07 (−0.14, 0.00006) 0.0498 −0.06 (−0.13, 0.01) 0.0952
  DDS average score −0.86 (−1.23, −0.48) <0.0001 −0.66 (−1.04, −0.29) 0.0005
 Somatic and cognitive-affective depressive symptoms
  PHQ-8 somatic symptom score −0.50 (−1.12, 0.11) 0.1099 −0.60 (−1.22, 0.01) 0.0548
  PHQ-8 cognitive-affective score −0.47 (−1.09, 0.16) 0.1429 −0.18 (−0.80, 0.44) 0.5742

Text in bold indicates a statistically significant relationship (< 0.01). *The adjusted linear mixed-effects model estimates the medication adherence at a subsequent follow-up visit as a function of the emotional distress factors with adjustment for age, sex, race/ethnicity, randomized treatment group, and longitudinal duration of T2DM, BMI, and HbA1c.